One-Stop Resource Helps Patients and Healthcare Providers Link to COVID-19 Clinical Trials and Expanded Access Programs
To help patients, caregivers, physicians, and other healthcare providers find COVID-19 treatment resources as quickly and easily as possible, the Reagan-Udall Foundation for the FDA today launched the online COVID-19 Treatment Hub.
The Hub is a critical enhancement to the existing Expanded Access Navigator, which was developed at the request of the U.S. Food and Drug Administration to help facilitate pre-approval access to drugs. The Hub helps users sift through the new clinical trials being announced every day as government, academia, and the global biopharmaceutical industry rally to find solutions to the pandemic.
“We are facing a health challenge unlike any of us have experienced in our lifetimes,” said Ellen Sigal, PhD, Chair of the Reagan-Udall Foundation. “We are grateful to work with FDA to make it easier for the public and for healthcare providers to navigate through the information and to find credible resources in one place.”
The COVID-19 Treatment Hub includes a directory of companies developing COVID-19 therapies, a searchable listing of relevant clinical trials and expanded access opportunities culled from ClinicalTrials.gov, and links to the latest FDA, CDC, and NIH updates. In addition to medical interventions, the COVID-19 Treatment Hub also links to key FDA resources for consumers and industry focused on food and veterinary safety.
“This pandemic is a scary journey for a lot of people right now,” says Andrew C. von Eschenbach, MD, 20th Commissioner of the FDA and a current member of the Foundation’s Board of Directors. “The new COVID-19 Treatment Hub holds the user’s hand and walks through the process of identifying available options and taking the next step.”